News & Updates

Show Multimedia Only
ASCL1 a potential therapeutic target for treating Cushing’s disease
ASCL1 a potential therapeutic target for treating Cushing’s disease
20 Aug 2022

A recent study attempting to understand the pathogenesis of Cushing’s disease (CD) suggests the potential of achaete-scute complex homolog 1 (ASCL1), a pioneer transcription factor, as a therapeutic target for the treatment of CD.

ASCL1 a potential therapeutic target for treating Cushing’s disease
20 Aug 2022
Poor mental health raises risk of incident T2D
Poor mental health raises risk of incident T2D
18 Aug 2022

People with worse overall psychological wellbeing are at significantly higher risk of developing type 2 diabetes (T2D) in a dose‒response manner irrespective of their genetic predisposition, suggest the results of a recent study.

Poor mental health raises risk of incident T2D
18 Aug 2022
Counseling intervention helps avert weight gain in midlife women
Counseling intervention helps avert weight gain in midlife women
15 Aug 2022

Women who are trying to prevent obesity during midlife may benefit from counseling interventions, which a recent study has shown to result in modest differences in weight change without causing any significant harm.

Counseling intervention helps avert weight gain in midlife women
15 Aug 2022
Variations in ambulant glucose tied to severe hypoglycaemia, unawareness of episode in T1D
Variations in ambulant glucose tied to severe hypoglycaemia, unawareness of episode in T1D
12 Aug 2022

In patients with type 1 diabetes (T1D), the coefficient of variation (CV) of ambulant glucose levels appears to be correlated with severe hypoglycaemia episodes and unawareness of hypoglycaemia, a recent Japan study has found.

Variations in ambulant glucose tied to severe hypoglycaemia, unawareness of episode in T1D
12 Aug 2022